Incidence, Risk Factors, and Outcome of Traumatic Tricuspid Regurgitation After Percutaneous Ventricular Lead Removal

Franceschi, Frédéric; Thuny, Franck; Giorgi, Roch; Sanaa, I.; Peyrouse, Eric; Assouan, X.; Prévôt, Sébastien; Bastard, Emilie; Habib, Gilbert; Deharo, Jean‐Claude

doi:10.1016/j.jacc.2009.02.045

Cited by 74 publications

(77 citation statements)

References 24 publications

(30 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The primary approach consisted of endovascular lead extraction as previously described 13. Outcomes were classified according to standard guidelines 6 14.…”

Section: Methodsmentioning

confidence: 99%

Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study

Deharo

Quatre²,

Mancini³

et al. 2012

Heart

Self Cite

128

111

View full text Add to dashboard Cite

show abstract

“…The primary approach consisted of endovascular lead extraction as previously described 13. Outcomes were classified according to standard guidelines 6 14.…”

Section: Methodsmentioning

confidence: 99%

Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study

Deharo

Quatre²,

Mancini³

et al. 2012

Heart

Self Cite

128

111

View full text Add to dashboard Cite

show abstract

“…Сама процедура экстракции электродов несет в себе риск нарушения функции ТК и раз-вития или ухудшения ТР [9,35]. Независимыми предикторами развития ТР после экстракции электродов являются: использование различно-го оборудования, включая лазерную экстрак-цию, удаление одновременно двух и более желу-дочковых электродов и длительность нахожде-ния электрода в организме пациента [36]. Частота встречаемости ТР после экстракции электродов относительно невелика и составляет около 9% [36].…”

Section: имплантация антиаритмических устройств является методом выбоunclassified

“…Независимыми предикторами развития ТР после экстракции электродов являются: использование различно-го оборудования, включая лазерную экстрак-цию, удаление одновременно двух и более желу-дочковых электродов и длительность нахожде-ния электрода в организме пациента [36]. Частота встречаемости ТР после экстракции электродов относительно невелика и составляет около 9% [36]. Обычно ТР является незначи-тельной или умеренной, выраженная ТР после удаления желудочковых электродов достаточно редка [37,38].…”

Section: имплантация антиаритмических устройств является методом выбоunclassified

Tricuspid Valve Regurgitation After Antiarrhythmic Device Implantation

Кропоткин¹,

Ivanitskiy²

2017

Ann aritmol

View full text Add to dashboard Cite

“…15,[20][21][22][23][24][25] If patients are pacemaker dependent, a temporary pacer is placed at or before the time of exchange. 15,23 Reimplantation of devices, if necessary, depends on the location of the infection.…”

Section: Pacemakersmentioning

confidence: 99%

Treatment of Infected Cardiac Implantable Electronic Devices

Fakhro

Jalalabadi

Brown

et al. 2016

Seminars in Plastic Surgery

View full text Add to dashboard Cite

Since their earliest application, cardiac implantable electronic devices (CIEDs), such as pacemakers, implantable defibrillators, and left ventricular assist devices (LVADs), have proven beneficial in the prevention of fatal cardiac-related disorders. 1 The past 50 years have seen a sharp rise in cardiac implantable device use with a resultant decline in deaths from ischemic, myocardial, and cardiac rhythm causes. 2 As the indications and guidelines governing CIED use broaden, so too does their widespread employment. 3 The rate of CIED infections has mirrored their increased use with some studies suggesting that the rate of device infections has overshadowed their implantation rate. 4 Infections pose a severe burden on patients, lead to significant health care costs and lengthy hospital stays, and may also lead to mortality. 5 When compared with noninfectious cardiac device complications, pacemaker infections result in an 8.4-to 11.6-fold increase in mortality rates along with a mean hospitalization cost ranging from $31,149 to $55,003. 6 Although both pacemakers and LVADs are implantable cardiac devices, their infection profile and treatment differ significantly due to the size of the device and the need for an external power source for the LVAD. However, both demonstrate a wide range of infection rates, with the true incidence of infection remaining elusive. 7 Topkara et al report a pacemaker infection rate of between 13% and 80%; however, others estimate it to be between 2% and 4% with rates rising 124% between years 1990 to 1999 and a 57% rise from 2004 to 2006, respectively. 8,9 Similarly, infection rates related to LVAD placement demonstrate a large range of between 13% and 80% among recipients. 10 This wide variability in infection risk is in part due to different types of infections that have been included under the category of CIED-related infections. Various reports broadly included patients with surgical site infections, postoperative pneumonia, central venous catheter-related sepsis, and nosocomial urinary tract infections, in addition to infection of the CIED. 10 Various comorbidities may contribute to CIED infections. Patients of advanced age, with congestive heart failure, with a metastatic malignancy, on corticosteroid therapy, or with renal failure are more likely to develop CIED infections thereby increasing their mortality. 9 Device Infection Diagnosis PacemakersThe diagnosis of pacemaker infections is often challenging. Pocket site infections are diagnosed clinically, often presenting with inflammatory skin changes including pain, swelling, AbstractWith their rising benefits, cardiac implantable electronic devices (CIEDs) such as pacemakers and left ventricular assist devices (LVADs) have witnessed a sharp rise in use over the past 50 years. As indications for use broaden, so too does their widespread employment with its attendant rise of CIED infections. Such large numbers of infections have inspired various algorithms mandating treatment. Early diagnosis of inciting organisms is crucial to...

show abstract

Incidence, Risk Factors, and Outcome of Traumatic Tricuspid Regurgitation After Percutaneous Ventricular Lead Removal

Abstract: This study found that TTR is not uncommon after percutaneous lead removal. It is strongly associated with the use of additional tools beyond simple traction and also with female sex. In the long term, right-sided heart failure is frequent in patients with severe TTR.

Cited by 74 publications

References 24 publications

Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study

Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study

Tricuspid Valve Regurgitation After Antiarrhythmic Device Implantation

Treatment of Infected Cardiac Implantable Electronic Devices

Contact Info

Product

Resources

About